Stable Isotope Labeled Nivolumab Biosimilar – Anti-PD1 mAb – Research Grade
Size | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Isotope Labeled Nivolumab Biosimilar - Anti-PD1 mAb - Research Grade |
---|---|
Source | DrugBank DB09035 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 143kDa |
Purity | >90% |
Buffer | PBS pH7.5 |
Delivery condition | Blue Ice |
Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Aliases /Synonyms | Nivolumab |
Reference | PX-TA1004-SIL |
Related Products | PX-P4116 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4 |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2 |
Isotopic Enrichment | 99% |
Stability | 1 year |
Formula | C6362H9862N1712O1995S42 |
General information about Nivolumab
Nivolumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Related products
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.